The global RNA Sample Preservation Solution market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
RNA Sample Preservation Solution is a non-toxic liquid that stabilizes and protects cellular RNA in various samples including animal tissue, bacteria, soil, stool and plant.
The RNA Sample Preservation Solution market is surging on the crest of a biotechnological wave, fueled by:
Growing adoption of RNA-based research: RNA"s role in understanding gene expression and disease mechanisms drives demand for reliable preservation solutions.
Advancements in RNA sequencing and analysis: Increased sensitivity and affordability of RNA sequencing techniques unlock new avenues for research and diagnostics.
Expansion of personalized medicine: Personalized medicine relies heavily on RNA analysis, further bolstering market demand.
Rise of liquid biopsies: Minimally invasive liquid biopsies using circulating RNA are gaining traction, necessitating stable sample preservation.
Challenges and Opportunities:
Competition and price pressure: Intense competition, particularly from low-cost manufacturers, can impact profit margins.
Stringent regulations and certifications: Complying with quality and safety standards can be complex and costly.
Evolving research needs: Keeping pace with advancements in RNA-based technologies requires continuous innovation.
Sustainability concerns: Developing eco-friendly formulations and reducing plastic waste are growing priorities.
The 鈥淩NA Sample Preservation Solution Industry Forecast鈥� looks at past sales and reviews total world RNA Sample Preservation Solution sales in 2024, providing a comprehensive analysis by region and market sector of projected RNA Sample Preservation Solution sales for 2025 through 2031. With RNA Sample Preservation Solution sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world RNA Sample Preservation Solution industry.
This Insight Report provides a comprehensive analysis of the global RNA Sample Preservation Solution landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on RNA Sample Preservation Solution portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global RNA Sample Preservation Solution market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for RNA Sample Preservation Solution and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global RNA Sample Preservation Solution.
This report presents a comprehensive overview, market shares, and growth opportunities of RNA Sample Preservation Solution market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Inactivated
Non-inactivated
Segmentation by Application:
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Longhorn Vaccines and Diagnostics
EKF Diagnostics Holdings
Biosigma
BIOBASE
BD
Aptaca
Puritan Medical
Hardy Diagnostics
Orient Gene
Jiangsu Zhongke Longchang Biological Technology Co., Ltd.
Improve Medical
Mole Bioscience
CWBIO
Biocomma
Beijing Hanbaihan Medical
Hybribio
Darui Biotech
Hangzhou LifeReal Biotechnology
Key Questions Addressed in this Report
What is the 10-year outlook for the global RNA Sample Preservation Solution market?
What factors are driving RNA Sample Preservation Solution market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do RNA Sample Preservation Solution market opportunities vary by end market size?
How does RNA Sample Preservation Solution break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global RNA Sample Preservation Solution Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for RNA Sample Preservation Solution by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for RNA Sample Preservation Solution by Country/Region, 2020, 2024 & 2031
2.2 RNA Sample Preservation Solution Segment by Type
2.2.1 Inactivated
2.2.2 Non-inactivated
2.3 RNA Sample Preservation Solution Sales by Type
2.3.1 Global RNA Sample Preservation Solution Sales Market Share by Type (2020-2025)
2.3.2 Global RNA Sample Preservation Solution Revenue and Market Share by Type (2020-2025)
2.3.3 Global RNA Sample Preservation Solution Sale Price by Type (2020-2025)
2.4 RNA Sample Preservation Solution Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 RNA Sample Preservation Solution Sales by Application
2.5.1 Global RNA Sample Preservation Solution Sale Market Share by Application (2020-2025)
2.5.2 Global RNA Sample Preservation Solution Revenue and Market Share by Application (2020-2025)
2.5.3 Global RNA Sample Preservation Solution Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global RNA Sample Preservation Solution Breakdown Data by Company
3.1.1 Global RNA Sample Preservation Solution Annual Sales by Company (2020-2025)
3.1.2 Global RNA Sample Preservation Solution Sales Market Share by Company (2020-2025)
3.2 Global RNA Sample Preservation Solution Annual Revenue by Company (2020-2025)
3.2.1 Global RNA Sample Preservation Solution Revenue by Company (2020-2025)
3.2.2 Global RNA Sample Preservation Solution Revenue Market Share by Company (2020-2025)
3.3 Global RNA Sample Preservation Solution Sale Price by Company
3.4 Key Manufacturers RNA Sample Preservation Solution Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers RNA Sample Preservation Solution Product Location Distribution
3.4.2 Players RNA Sample Preservation Solution Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for RNA Sample Preservation Solution by Geographic Region
4.1 World Historic RNA Sample Preservation Solution Market Size by Geographic Region (2020-2025)
4.1.1 Global RNA Sample Preservation Solution Annual Sales by Geographic Region (2020-2025)
4.1.2 Global RNA Sample Preservation Solution Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic RNA Sample Preservation Solution Market Size by Country/Region (2020-2025)
4.2.1 Global RNA Sample Preservation Solution Annual Sales by Country/Region (2020-2025)
4.2.2 Global RNA Sample Preservation Solution Annual Revenue by Country/Region (2020-2025)
4.3 Americas RNA Sample Preservation Solution Sales Growth
4.4 APAC RNA Sample Preservation Solution Sales Growth
4.5 Europe RNA Sample Preservation Solution Sales Growth
4.6 Middle East & Africa RNA Sample Preservation Solution Sales Growth
5 Americas
5.1 Americas RNA Sample Preservation Solution Sales by Country
5.1.1 Americas RNA Sample Preservation Solution Sales by Country (2020-2025)
5.1.2 Americas RNA Sample Preservation Solution Revenue by Country (2020-2025)
5.2 Americas RNA Sample Preservation Solution Sales by Type (2020-2025)
5.3 Americas RNA Sample Preservation Solution Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC RNA Sample Preservation Solution Sales by Region
6.1.1 APAC RNA Sample Preservation Solution Sales by Region (2020-2025)
6.1.2 APAC RNA Sample Preservation Solution Revenue by Region (2020-2025)
6.2 APAC RNA Sample Preservation Solution Sales by Type (2020-2025)
6.3 APAC RNA Sample Preservation Solution Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe RNA Sample Preservation Solution by Country
7.1.1 Europe RNA Sample Preservation Solution Sales by Country (2020-2025)
7.1.2 Europe RNA Sample Preservation Solution Revenue by Country (2020-2025)
7.2 Europe RNA Sample Preservation Solution Sales by Type (2020-2025)
7.3 Europe RNA Sample Preservation Solution Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa RNA Sample Preservation Solution by Country
8.1.1 Middle East & Africa RNA Sample Preservation Solution Sales by Country (2020-2025)
8.1.2 Middle East & Africa RNA Sample Preservation Solution Revenue by Country (2020-2025)
8.2 Middle East & Africa RNA Sample Preservation Solution Sales by Type (2020-2025)
8.3 Middle East & Africa RNA Sample Preservation Solution Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of RNA Sample Preservation Solution
10.3 Manufacturing Process Analysis of RNA Sample Preservation Solution
10.4 Industry Chain Structure of RNA Sample Preservation Solution
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 RNA Sample Preservation Solution Distributors
11.3 RNA Sample Preservation Solution Customer
12 World Forecast Review for RNA Sample Preservation Solution by Geographic Region
12.1 Global RNA Sample Preservation Solution Market Size Forecast by Region
12.1.1 Global RNA Sample Preservation Solution Forecast by Region (2026-2031)
12.1.2 Global RNA Sample Preservation Solution Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global RNA Sample Preservation Solution Forecast by Type (2026-2031)
12.7 Global RNA Sample Preservation Solution Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Thermo Fisher Scientific
13.1.1 Thermo Fisher Scientific Company Information
13.1.2 Thermo Fisher Scientific RNA Sample Preservation Solution Product Portfolios and Specifications
13.1.3 Thermo Fisher Scientific RNA Sample Preservation Solution Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Thermo Fisher Scientific Main Business Overview
13.1.5 Thermo Fisher Scientific Latest Developments
13.2 Longhorn Vaccines and Diagnostics
13.2.1 Longhorn Vaccines and Diagnostics Company Information
13.2.2 Longhorn Vaccines and Diagnostics RNA Sample Preservation Solution Product Portfolios and Specifications
13.2.3 Longhorn Vaccines and Diagnostics RNA Sample Preservation Solution Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Longhorn Vaccines and Diagnostics Main Business Overview
13.2.5 Longhorn Vaccines and Diagnostics Latest Developments
13.3 EKF Diagnostics Holdings
13.3.1 EKF Diagnostics Holdings Company Information
13.3.2 EKF Diagnostics Holdings RNA Sample Preservation Solution Product Portfolios and Specifications
13.3.3 EKF Diagnostics Holdings RNA Sample Preservation Solution Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 EKF Diagnostics Holdings Main Business Overview
13.3.5 EKF Diagnostics Holdings Latest Developments
13.4 Biosigma
13.4.1 Biosigma Company Information
13.4.2 Biosigma RNA Sample Preservation Solution Product Portfolios and Specifications
13.4.3 Biosigma RNA Sample Preservation Solution Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Biosigma Main Business Overview
13.4.5 Biosigma Latest Developments
13.5 BIOBASE
13.5.1 BIOBASE Company Information
13.5.2 BIOBASE RNA Sample Preservation Solution Product Portfolios and Specifications
13.5.3 BIOBASE RNA Sample Preservation Solution Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 BIOBASE Main Business Overview
13.5.5 BIOBASE Latest Developments
13.6 BD
13.6.1 BD Company Information
13.6.2 BD RNA Sample Preservation Solution Product Portfolios and Specifications
13.6.3 BD RNA Sample Preservation Solution Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 BD Main Business Overview
13.6.5 BD Latest Developments
13.7 Aptaca
13.7.1 Aptaca Company Information
13.7.2 Aptaca RNA Sample Preservation Solution Product Portfolios and Specifications
13.7.3 Aptaca RNA Sample Preservation Solution Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Aptaca Main Business Overview
13.7.5 Aptaca Latest Developments
13.8 Puritan Medical
13.8.1 Puritan Medical Company Information
13.8.2 Puritan Medical RNA Sample Preservation Solution Product Portfolios and Specifications
13.8.3 Puritan Medical RNA Sample Preservation Solution Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Puritan Medical Main Business Overview
13.8.5 Puritan Medical Latest Developments
13.9 Hardy Diagnostics
13.9.1 Hardy Diagnostics Company Information
13.9.2 Hardy Diagnostics RNA Sample Preservation Solution Product Portfolios and Specifications
13.9.3 Hardy Diagnostics RNA Sample Preservation Solution Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Hardy Diagnostics Main Business Overview
13.9.5 Hardy Diagnostics Latest Developments
13.10 Orient Gene
13.10.1 Orient Gene Company Information
13.10.2 Orient Gene RNA Sample Preservation Solution Product Portfolios and Specifications
13.10.3 Orient Gene RNA Sample Preservation Solution Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Orient Gene Main Business Overview
13.10.5 Orient Gene Latest Developments
13.11 Jiangsu Zhongke Longchang Biological Technology Co., Ltd.
13.11.1 Jiangsu Zhongke Longchang Biological Technology Co., Ltd. Company Information
13.11.2 Jiangsu Zhongke Longchang Biological Technology Co., Ltd. RNA Sample Preservation Solution Product Portfolios and Specifications
13.11.3 Jiangsu Zhongke Longchang Biological Technology Co., Ltd. RNA Sample Preservation Solution Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Jiangsu Zhongke Longchang Biological Technology Co., Ltd. Main Business Overview
13.11.5 Jiangsu Zhongke Longchang Biological Technology Co., Ltd. Latest Developments
13.12 Improve Medical
13.12.1 Improve Medical Company Information
13.12.2 Improve Medical RNA Sample Preservation Solution Product Portfolios and Specifications
13.12.3 Improve Medical RNA Sample Preservation Solution Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Improve Medical Main Business Overview
13.12.5 Improve Medical Latest Developments
13.13 Mole Bioscience
13.13.1 Mole Bioscience Company Information
13.13.2 Mole Bioscience RNA Sample Preservation Solution Product Portfolios and Specifications
13.13.3 Mole Bioscience RNA Sample Preservation Solution Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Mole Bioscience Main Business Overview
13.13.5 Mole Bioscience Latest Developments
13.14 CWBIO
13.14.1 CWBIO Company Information
13.14.2 CWBIO RNA Sample Preservation Solution Product Portfolios and Specifications
13.14.3 CWBIO RNA Sample Preservation Solution Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 CWBIO Main Business Overview
13.14.5 CWBIO Latest Developments
13.15 Biocomma
13.15.1 Biocomma Company Information
13.15.2 Biocomma RNA Sample Preservation Solution Product Portfolios and Specifications
13.15.3 Biocomma RNA Sample Preservation Solution Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Biocomma Main Business Overview
13.15.5 Biocomma Latest Developments
13.16 Beijing Hanbaihan Medical
13.16.1 Beijing Hanbaihan Medical Company Information
13.16.2 Beijing Hanbaihan Medical RNA Sample Preservation Solution Product Portfolios and Specifications
13.16.3 Beijing Hanbaihan Medical RNA Sample Preservation Solution Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Beijing Hanbaihan Medical Main Business Overview
13.16.5 Beijing Hanbaihan Medical Latest Developments
13.17 Hybribio
13.17.1 Hybribio Company Information
13.17.2 Hybribio RNA Sample Preservation Solution Product Portfolios and Specifications
13.17.3 Hybribio RNA Sample Preservation Solution Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Hybribio Main Business Overview
13.17.5 Hybribio Latest Developments
13.18 Darui Biotech
13.18.1 Darui Biotech Company Information
13.18.2 Darui Biotech RNA Sample Preservation Solution Product Portfolios and Specifications
13.18.3 Darui Biotech RNA Sample Preservation Solution Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Darui Biotech Main Business Overview
13.18.5 Darui Biotech Latest Developments
13.19 Hangzhou LifeReal Biotechnology
13.19.1 Hangzhou LifeReal Biotechnology Company Information
13.19.2 Hangzhou LifeReal Biotechnology RNA Sample Preservation Solution Product Portfolios and Specifications
13.19.3 Hangzhou LifeReal Biotechnology RNA Sample Preservation Solution Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 Hangzhou LifeReal Biotechnology Main Business Overview
13.19.5 Hangzhou LifeReal Biotechnology Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
